Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-09 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2023-02-06 | New | $200,000 | $200,000 | Equity Only | 06b | SEC link |
| 2021-02-17 | New | $25,000 | $25,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Paul Brennan | Director |
| Robert Klem | Director |
| Dayton Reardan | Director, Executive, Promoter |
| Daniel Saccani | Director |
| Patrick Schlievert | Director |